Catherine M. Lockhart, PharmD, PhD

Chief Science Officer & Executive Dir, Biologics and Biosimilars Collective Intelligence Consortium
Academy of Managed Care Pharmacy Research Institute

Poster(s):

• (A-046) A Study of Granulocyte-Colony Stimulating Factor (G-CSF) Reference and Biosimilar Products using Real World Data to Emulate a Target Trial for Switching: A Biologics and Biosimilars Collective Intelligence Consortium Experience
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (SLA-037) Can observational studies replace experimental transition (or switching) studies for evaluating the interchangeability of biological drug reference and biosimilars? Methodological challenges and considerations
  Sunday, August 24, 2025

  12:15 PM - 1:15 PM ET